Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases

Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases

Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) is a novel laparoscopic intraperitoneal chemotherapy approach offered in selected patients affected by non-resectable peritoneal carcinomatosis. Drugs doses currently established for nebulization are very low: oxaliplatin (OXA) 120 mg/sm, cis...

Full description

Bibliographic Details
Main Authors: Manuela Robella, Paola Berchialla, Alice Borsano, Armando Cinquegrana, Alba Ilari Civit, Michele De Simone, Marco Vaira
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Environmental Research and Public Health
Subjects:
cisplatin
doxorubicin
oxaliplatin
dose escalation
phase I
PIPAC
Online Access:https://www.mdpi.com/1660-4601/18/11/5656

Internet

https://www.mdpi.com/1660-4601/18/11/5656

Similar Items